Literature DB >> 3105627

Increased factor VIII/vWf levels in patients with reduced platelet number.

A Casonato, F Fabris, M Boscaro, A Girolami.   

Abstract

Factor VIII/von Willebrand factor (VIII/vWf) related properties were studied in twenty six patients with thrombocytopenia. Fifteen patients were affected by idiopathic thrombocytopenic purpura (ITP) and 11 patients by thrombocytopenia of a different nature or non-ITP (n-ITP). All patients showed an enhancement of platelet associated IgG (PAIgG). A significant increase of factor VIII ristocetin cofactor (VIII R: RCoF) and factor VIII related antigen (VIII R:Ag) was found in ITP patients while normal values were observed for factor VIII coagulant (VIII:C). All factor VIII/vWf components, on the contrary, were increased in n-ITP group with a prevalence of VIII R:RCoF as observed in ITP group even though with lower mean values. Multimeric analysis of VIII/vWf demonstrated a higher concentration of all multimeric components, with major representation of higher molecular weight multimers (HMWM) in patients of both groups. Two patients were studied before and after improvement in platelet count. A decrease of vWf related properties (VIII R:RCoF and VIII R:Ag) concomitant with the increase in platelet count was found. In n-ITP patients a statistical correlation between VIII R:RCoF and PAIgG was also observed while no correlation was found between other factor VIII/vWf components and PAIgG both in ITP and n-ITP patients.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3105627     DOI: 10.1007/bf00320876

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  32 in total

1.  Letter: A method for assaying von Willebrand factor (ristocetin cofactor).

Authors:  D E Macfarlane; J Stibbe; E P Kirby; M B Zucker; R A Grant; J McPherson
Journal:  Thromb Diath Haemorrh       Date:  1975-09-30

2.  Abnormalities of von Willebrand factor in myeloproliferative disease: a relationship with bleeding diathesis.

Authors:  F Fabris; A Casonato; M Grazia del Ben; L De Marco; A Girolami
Journal:  Br J Haematol       Date:  1986-05       Impact factor: 6.998

3.  Human blood platelet adhesion to artery subendothelium is mediated by factor VIII-Von Willebrand factor bound to the subendothelium.

Authors:  K S Sakariassen; P A Bolhuis; J J Sixma
Journal:  Nature       Date:  1979-06-14       Impact factor: 49.962

4.  Effect of multimeric structure of the factor VIII/von Willebrand factor protein on binding to platelets.

Authors:  H R Gralnick; S B Williams; D K Morisato
Journal:  Blood       Date:  1981-08       Impact factor: 22.113

5.  von Willebrand factor interaction with the glycoprotein IIb/IIa complex. Its role in platelet function as demonstrated in patients with congenital afibrinogenemia.

Authors:  L De Marco; A Girolami; T S Zimmerman; Z M Ruggeri
Journal:  J Clin Invest       Date:  1986-04       Impact factor: 14.808

6.  Platelets in myeloproliferative disorders. III: Glycoprotein profile in relation to platelet function and platelet density.

Authors:  N Eche; P Sie; C Caranobe; C Nouvel; J Pris; B Boneu
Journal:  Scand J Haematol       Date:  1981-02

7.  Platelets have more than one binding site for von Willebrand factor.

Authors:  Z M Ruggeri; L De Marco; L Gatti; R Bader; R R Montgomery
Journal:  J Clin Invest       Date:  1983-07       Impact factor: 14.808

8.  Studies with a murine monoclonal antibody that abolishes ristocetin-induced binding of von Willebrand factor to platelets: additional evidence in support of GPIb as a platelet receptor for von Willebrand factor.

Authors:  B S Coller; E I Peerschke; L E Scudder; C A Sullivan
Journal:  Blood       Date:  1983-01       Impact factor: 22.113

9.  The role of ADP secretion and thromboxane synthesis in factor VIII binding to platelets.

Authors:  G Di Minno; S S Shapiro; P M Catalano; L De Marco; S Murphy
Journal:  Blood       Date:  1983-07       Impact factor: 22.113

10.  A new method for the simultaneous quantitation of platelet-bound immunoglobuin (IgG) and complement (C3) employing an enzyme-linked immunosorbent assay (ELISA) procedure.

Authors:  J D Nel; K Stevens
Journal:  Br J Haematol       Date:  1980-02       Impact factor: 6.998

View more
  2 in total

1.  A characteristic flow cytometric pattern with broad forward scatter and narrowed side scatter helps diagnose immune thrombocytopenia (ITP).

Authors:  Raita Araki; Ryosei Nishimura; Rie Kuroda; Toshihiro Fujiki; Shintaro Mase; Kazuhiro Noguchi; Yasuhiro Ikawa; Hideaki Maeba; Akihiro Yachie
Journal:  Int J Hematol       Date:  2018-04-16       Impact factor: 2.490

Review 2.  Pathogenesis of Two Faces of DVT: New Identity of Venous Thromboembolism as Combined Micro-Macrothrombosis via Unifying Mechanism Based on "Two-Path Unifying Theory" of Hemostasis and "Two-Activation Theory of the Endothelium".

Authors:  Jae C Chang
Journal:  Life (Basel)       Date:  2022-01-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.